Cancer Medicines Outcomes Programme Public Health Scotland (CMOP-PHS) report
SACT treatment for adults with metastatic colorectal cancer (NCMAG123)
Management information
- Published
- 22 July 2025 (Latest release)
- Type
- Statistical report
- Author
- Public Health Scotland
About this release
This release by Public Health Scotland (PHS) uses information from the National SACT dataset.
This work was requested by the National Cancer Medicines Advisory Group (NCMAG) to support their decision-making processes. NCMAG are assessing the use of bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment (NCMAG123) and second-line treatment (NCMAG124) of adult patients with metastatic carcinoma of the colon or rectum.
It was not possible to accurately identify patients who received second-line SACT for metastatic colorectal cancer (NCMAG124). Therefore, the aim of this work was to capture real-world evidence on the use of SACT for first-line treatment of adult patients with metastatic colorectal cancer only (NCMAG123). This work will enable NCMAG members to assess the relevancy of information, provided as part of the assessment process, to patients in Scotland.
The objectives of this work were to:
- Determine the number of patients prescribed first-line SACT for metastatic colorectal cancer
- Describe the baseline characteristics of patients prescribed SACT as a first-line treatment for metastatic colorectal cancer
- Describe the first-line treatment characteristics including duration of treatment and subsequent treatment.
General enquiries
If you have an enquiry relating to this publication, please contact Kimberley Philip at phs.cmop@phs.scot.
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.
Older versions of this publication
Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.